Hu Yi, Li Genlin, Ma Yan, Luo Guifang, Wang Qian, Zhang Shufen
Department of Obstetrics and Gynaecology, The First Affiliated Hospital of Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China.
J Oncol. 2023 Feb 6;2023:6341011. doi: 10.1155/2023/6341011. eCollection 2023.
Exosomes can encapsulate lncRNA to mediate intercellular communication in cancer progression. Our study devoted to research the effect that long noncoding RNA Metastasis-associated lung adenocarcinoma transcript 1 (lncRNA MALAT1) influence on cervical cancer (CC).
MALAT1 and miR-370-3p levels in CC was assessed using qRT-PCR. CCK-8 assay and flow cytometry were devoted to confirm the influence on MALAT1 influencing the proliferation in cisplatin-resistant CC cells. Futher more, MALAT1, combined with miR-370-3p was confirmed by dual-luciferase reporter assay and RNA immunoprecipitation assay.
In CC tissues, MALAT1 turned into substantially expressed, cisplatin-resistant cell lines, as well as exosomes. Cell proliferation was restrained and cisplatin-induced apoptosis was promoted by way of Knockout MALAT1. And promoted the miR-370-3p level, MALAT1 targeted miR-370-3p. Promoting effect of MALAT1 on cisplatin resistance of CC was partially reversed through miR-370-3p. In addition, STAT3 may induce up-regulation of MALAT1 expression in cisplatin-resistant CC cells. It was further confirmed that the effect of MALAT1 on cisplatin-resistant CC cells was achieved by activating PI3K/Akt pathway.
The positive feedback loop of exosomal MALAT1/miR-370-3p/STAT3 mediates the cisplatin resistance of cervical cancer cells affecting PI3K/Akt pathway. Exosomal MALAT1 may become a promising therapeutic target for treating cervical cancer.
外泌体可以包裹长链非编码RNA(lncRNA),在癌症进展过程中介导细胞间通讯。我们的研究致力于探究长链非编码RNA转移相关肺腺癌转录本1(lncRNA MALAT1)对宫颈癌(CC)的影响。
采用qRT-PCR检测CC中MALAT1和miR-370-3p的水平。使用CCK-8法和流式细胞术确定MALAT1对顺铂耐药CC细胞增殖的影响。此外,通过双荧光素酶报告基因检测和RNA免疫沉淀检测证实MALAT1与miR-370-3p的结合。
在CC组织、顺铂耐药细胞系以及外泌体中,MALAT1均高表达。敲除MALAT1可抑制细胞增殖并促进顺铂诱导的细胞凋亡。MALAT1靶向miR-370-3p并促进其表达。miR-370-3p可部分逆转MALAT1对CC顺铂耐药的促进作用。此外,STAT3可能诱导顺铂耐药CC细胞中MALAT1表达上调。进一步证实MALAT1对顺铂耐药CC细胞的作用是通过激活PI3K/Akt通路实现的。
外泌体MALAT1/miR-370-3p/STAT3正反馈环介导宫颈癌细胞的顺铂耐药,影响PI3K/Akt通路。外泌体MALAT1可能成为治疗宫颈癌的一个有前景的治疗靶点。